Kim Nam-Ho, Rincon-Choles Hernan, Bhandari Basant, Choudhury Goutam Ghosh, Abboud Hanna E, Gorin Yves
University of Texas Health Science Center, Department of Medicine, Division of Nephrology, MC 7882, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA.
Am J Physiol Renal Physiol. 2006 Mar;290(3):F741-51. doi: 10.1152/ajprenal.00313.2005. Epub 2005 Oct 18.
Podocytes or glomerular epithelial cells (GECs) are important targets of the diabetic microenvironment. Podocyte foot process effacement and widening, loss of GECs and hypertrophy are pathological features of this disease. ANG II and oxidative stress are key mediators of renal hypertrophy in diabetes. The cellular mechanisms responsible for GEC hypertrophy in diabetes are incompletely characterized. We investigated the effect of high glucose on protein synthesis and GEC hypertrophy. Exposure of GECs to high glucose dose dependently stimulated [(3)H]leucine incorporation, but not [(3)H]thymidine incorporation. High glucose resulted in the activation of ERK1/2 and Akt/PKB. ERK1/2 pathway inhibitor or the dominant negative mutant of Akt/PKB inhibited high glucose-induced protein synthesis. High glucose elicited a rapid generation of reactive oxygen species (ROS). The stimulatory effect of high glucose on ROS production, ERK1/2, and Akt/PKB activation was prevented by the antioxidants catalase, diphenylene iodonium, and N-acetylcysteine. Exposure of the cells to hydrogen peroxide mimicked the effects of high glucose. In addition, ANG II resulted in the activation of ERK1/2 and Akt/PKB and GEC hypertrophy. Moreover, high glucose and ANG II exhibited additive effects on ERK1/2 and Akt/PKB activation as well as protein synthesis. These additive responses were abolished by treatment of the cells with the antioxidants. These data demonstrate that high glucose stimulates GEC hypertrophy through a ROS-dependent activation of ERK1/2 and Akt/PKB. Enhanced ROS generation accounts for the additive effects of high glucose and ANG II, suggesting that this signaling cascade contributes to GEC injury in diabetes.
足细胞或肾小球上皮细胞(GECs)是糖尿病微环境的重要靶点。足细胞足突消失和增宽、GECs丢失以及肥大是该疾病的病理特征。血管紧张素II(ANG II)和氧化应激是糖尿病肾肥大的关键介质。糖尿病中导致GECs肥大的细胞机制尚未完全明确。我们研究了高糖对蛋白质合成和GECs肥大的影响。将GECs暴露于高糖环境下,剂量依赖性地刺激了[³H]亮氨酸掺入,但不影响[³H]胸腺嘧啶掺入。高糖导致细胞外信号调节激酶1/2(ERK1/2)和蛋白激酶B(Akt/PKB)的激活。ERK1/2通路抑制剂或Akt/PKB的显性负突变体抑制了高糖诱导的蛋白质合成。高糖引发了活性氧(ROS)的快速产生。抗氧化剂过氧化氢酶、二苯基碘鎓和N - 乙酰半胱氨酸可阻止高糖对ROS产生、ERK1/2和Akt/PKB激活的刺激作用。将细胞暴露于过氧化氢可模拟高糖的作用。此外,ANG II导致ERK1/2和Akt/PKB的激活以及GECs肥大。而且,高糖和ANG II对ERK1/2和Akt/PKB的激活以及蛋白质合成表现出相加作用。用抗氧化剂处理细胞可消除这些相加反应。这些数据表明,高糖通过ROS依赖性激活ERK1/2和Akt/PKB刺激GECs肥大。ROS生成增加解释了高糖和ANG II的相加作用,提示该信号级联反应导致糖尿病中的GECs损伤。